United States · FDA National Drug Code directory

acyclovir

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
66267-399_1fa6dc86-6637-c362-e063-6394a90a4c03
Product NDC
66267-399
Form
TABLET
Composition / generic term
acyclovir
Labeler
NuCare Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20140910
Source listing expiry
20261231

Source-listed ingredients

  • ACYCLOVIR — 800 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 15 TABLET in 1 BOTTLE (66267-399-15) · 66267-399-15
  • 21 TABLET in 1 BOTTLE (66267-399-21) · 66267-399-21
  • 25 TABLET in 1 BOTTLE (66267-399-25) · 66267-399-25
  • 30 TABLET in 1 BOTTLE (66267-399-30) · 66267-399-30
  • 35 TABLET in 1 BOTTLE (66267-399-35) · 66267-399-35
  • 50 TABLET in 1 BOTTLE (66267-399-50) · 66267-399-50

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →